Beranda › Penyakit Arteri Koroner › New Jersey
Uji klinis Penyakit Arteri Koroner di New Jersey
15 studi untuk Penyakit Arteri Koroner mencari peserta di lokasi di New Jersey.
Kota di New Jersey
Teks studi resmi (Bahasa Inggris)
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
- Virtua Health, Camden
Menerima peserta
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07296744A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)
- HACKENSACK MERIDIAN HEALTH, Inc, Jersey City
Menerima peserta
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07286578Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- Advanced Heart Care LLC, Bridgewater
- Cardiovascular Associates of the Delaware Valley, Elmer
- Advanced Heart and Vascular Institute Of Hunterdon, Flemington
- dan 3 lainnya
Menerima pesertaFase 4
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06909565IVUS CHIP UPP Registry
- Barnabas Health, Jersey City
- Virtua Health, Marlton
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06625801Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Hypertension & Nephrology Association, Eatontown
- New Jersey Kidney Care, Jersey City
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT05485961Product Surveillance Registry
- Camden
- Marlton
- Morristown
- dan 2 lainnya
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT01524276REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities
- Englewood Hospital, Englewood
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06399705REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women
- Englewood Hospital, Englewood
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06399692Prevail Global Study
- Virtua Our Lady of Lourdes Hospital, Camden
- The Valley Hospital, Paramus
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Apr 2026 · NCT06535854Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
- Englewood Health, Englewood
- Newark Beth Israel Medical Center, Newark
- The Valley Hospital, Ridgewood
Menerima peserta
Usia 18 ke atas · Wanita · Diperbarui 1 Apr 2026 · NCT04124120MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
- Atlanticare Regional Medical Center, Pomona
Menerima peserta
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 11 Sep 2025 · NCT06271590Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
- Our Lady of Lourdes, Camden
- Valley Hospital, Ridgewood
Menerima peserta
Semua usia · Semua jenis kelamin · Diperbarui 24 Jul 2025 · NCT04634240Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
- RWJ Barnabas Health, Jersey City
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Jun 2025 · NCT05701358PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm
- Deborah Heart and Lung Center, Browns Mills
Menerima peserta
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 13 Jun 2025 · NCT06445608MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
- AtlantiCare Regional Medical Center, Pomona
Menerima peserta
Usia 18 hingga 110 · Semua jenis kelamin · Diperbarui 25 Feb 2025 · NCT05908331Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.